Blue Jet Healthcare Limited
Start Date25-10-2023
Application Timing10am-5pm
Price Range₹329 - ₹346
Min Qty43
Min. Investment₹14147
Listing DateNA
Close Date27-10-2023

About Blue Jet Healthcare Limited

Blue Jet Healthcare is a speciality pharmaceutical and healthcare ingredients and intermediates company, offering niche products to innovator pharmaceutical companies and multinational generic pharmaceutical companies. 

Since its incorporation in 1968, they have established a contract development and manufacturing organization (CDMO) business model (which provides critical ingredients to other pharma companies) in contrast media intermediates and high intensity sweeteners. 

Contrast media is used in medical imaging and scans. Sweetners are used in pharma, beverages, personal care, confectionery and food industry.

Company operates  in three product categories: (i) contrast media intermediates, (ii) high intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (APIs). 


The global pharma formulation market is estimated at USD 1,381 billion and is expected to grow at a CAGR of 5-6% to reach USD 1,700  billion by 2027.

The size of the global contrast-media formulations market is approx USD 5.9 billion and forecasted to grow at a CAGR of 6-8% between 2023-2025. Growing population and changing demographics, lifestyle diseases, rising healthcare expenditure, focus on early diagnosis and preventive care are factors for growth for this segment.

The global high-intensity sweetener market is estimated to be USD 3 billion in size and estimated to grow at a CAGR of 6% to 7% over next 5 years due to growing rate of diabetes and obesity, shifting consumer preference and rising urbanization.

Why To Invest in Blue Jet Healthcare Limited

Large manufacturer of specialty pharmaceutical and healthcare ingredients, offering niche products to global innovator pharmaceutical companies.

The IPO proceeds will not be used by the company. It will be received by the Selling Shareholders, in proportion to the Offered Shares sold by the respective Selling Shareholders as part of the Offer.

Strengths And Risks
Large Manufacturer: Blue Jet Healthcare is a large manufacturer of contrast media intermediates in India, with over 20 years experience in this segment. They supply critical ingredients to three of the largest contrast media manufacturers in the world, including GE Healthcare AS, Guerbet Group, and Bracco Imaging.
Niche Segment : Blue Jet Healthcare strategically focuses on complex chemistry categories in both the contrast media intermediate and high-intensity sweetener categories with high barriers to entry.
Long-standing Relationships: They have strong relationships with customers. They enter into annual and multi-year supply contracts providing strong predictability of order book revenue, and cashflow. More than 70% of our total sales is backed by annual or multi year contracts.
R&D Capability: They have a strong in-house govt recognised R&D centre. Over the past 50 years, they have developed over 100 products, with over 40 products commercialized.
Manufacturing Facilities: They have 3 manufacturing facilities in Maharashtra. These facilities have received accreditation from various regulatory agencies. In particular, one facility has been subject to US-FDA inspections in the FY 2018, and it received the USFDA establishment inspection report.
Geographic Concentration: They are dependent on Europe and the United States, which are regulated markets, for a significant portion of our revenue from operations. Any change in regulation can impact business.
Raw Material Sourcing: They depend on a limited number of raw material suppliers and three largest suppliers are located in China, Norway and India. Any delay or interruption in the supply or transportation of raw materials or cost increase can impact operations.
Foreign Exchange Risk: A significant portion of their total revenue from operations is denominated in currencies other than Indian Rupees, which exposes the business to forex fluctuation risk.
Government Regulations: Pharma industry is subject to extensive government regulations and if they fail to obtain or renew the required statutory licenses, permits and approvals, the business and cash flows may be adversely affected.
What is the Blue Jet Healthcare Limited IPO? +
When will the IPO open? +
What is the lot size of the IPO? +
How to apply for an IPO? +
When will the IPO be allotted? +
When is the IPO listing date? +

Explore Other Products

Rupeezy AppAdvanced charts, advanced Option Chain, instant pay-in & pay-out,margin .Learn More
Rupeezy <> TradingViewEnjoy top-class trading experience enhanced by advanced TradingView charts.Learn More
DockPortfolio analysis, pledge holdings, apply in IPOs & download reports Learn More